Jasper Therapeutics Inc.
(JSPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 19,166 | 27,076 | 21,802 | 25,285 | 19,889 |
| Operating Income | -19,166 | -27,076 | -21,802 | -25,285 | -19,889 |
| Other Income | 430 | 353 | 561 | 964 | 1,252 |
| Pre-tax Income | -18,736 | -26,723 | -21,241 | -24,321 | -18,637 |
| Net Income Continuous | -18,736 | -26,723 | -21,241 | -24,321 | -18,637 |
| Net Income | $-18,736 | $-26,723 | $-21,241 | $-24,321 | $-18,637 |
| EPS Basic Total Ops | -1.13 | -1.74 | -1.41 | -1.65 | -1.24 |
| EPS Basic Continuous Ops | -1.13 | -1.74 | -1.41 | -1.64 | -1.24 |
| EPS Diluted Total Ops | -1.13 | -1.74 | -1.41 | -1.65 | -1.24 |
| EPS Diluted Continuous Ops | -1.13 | -1.74 | -1.41 | -1.64 | -1.24 |
| EPS Diluted Before Non-Recurring Items | -1.13 | -1.74 | -1.41 | -1.62 | -1.24 |
| EBITDA(a) | $-18,937 | $-26,818 | $-21,523 | $-25,040 | $-19,348 |